Innovative Medicines Initiative (IMI)

1. Drug Discovery Exchange Fellowship Workshop 9th-10th DecemberMike HardmanIMI EMTRAIN Coordinator

2. Innovative Medicines Initiative (IMI)

3. The Problem Traditional “reductionist” approach 21st Century “systems” approach Predictive science Translational medicine Personalised health care Regulatory Science Modelling & Simulation Nanotechnology Collaborations Biology Pharmacology Chemistry Pharmacy Immunology Medicine Limited sharing of knowledge

4. A double rod pendulum animation showing chaotic behavior. Starting the pendulum from a slightly different initial condition would result in a completely different trajectory. The double rod pendulum is one of the simplest dynamic systems that has chaotic solutions. http://en.wikipedia.org/wiki/File:Double-compound-pendulum.gif

5. The solution Every professional in the biomedical sciences needs to develop and maintain an optimal level of professional competence, to speed up the development of bettermedicines for patients Better medicines for patients

6. European Medicines Research Training Network (EMTRAIN) European Programme in Pharmacovigilance and Pharmacoepidemiology (Eu2P) Pharmaceutical Medicines Training Programme (PharmaTrain) European Modular Education and Training Programme in Safety Sciences for Medicines (SafeSciMET) European Patients Academy on Therapeutic Innovation (EUPATI) IMI Education and Training Programmes

7. IMI EMTRAIN: Key Messages EMTRAIN strengthens the pan-European community of scientists in medicines development PhD programme We build a programme for public-private partnership PhD students who understand industry needs LifeTrain on-course® We ensure broad stakeholder support for 21st century skills, CPD and competency portfolios • We provide a comprehensive on-course® catalogue (www.on-course.eu) with quality indicators and tools/methodologies

8. on-course®: Find the right ‘course’ to develop and maintain your professional competence!

9. on-course® www.on-course.eu

10. A typical course page

11. A typical course page

12. IMI EMTRAIN: Key Messages EMTRAIN strengthens the pan-European community of scientists in medicines development PhD programme We build a programme for public-private partnership PhD students who understand industry needs LifeTrain on-course® We ensure broad stakeholder support for 21st century skills, CPD and competency portfolios • We provide a comprehensive on-course® catalogue (www.on-course.eu) with quality indicators and tools/methodologies

13. The IMI LifeTrain Framework Professional/ Scientific Bodies European Framework for continuing professional development (CPD) in the biomedical Sciences Support their members with defined competency profiles in their career planning Course Providers Individual Professionals/ Scientists Develop and provide quality CPD programmes which meet the employers needs and are aligned with professional/scientific bodies Employers Take responsibility for CPD and apply the‚ plan-do-report-review cycle Include CPD in individual development plans and to work with course providers and professional/ scientific bodies so that employers‘ needs are addressed

14. LifeTrain Messages An individual competency portfolio should capture all relevant information to facilitate mobility, and to support career development. Education CPD formal learning Practical work experience CPD informal learning CPD Transferable skills

15. LifeTrain “We now have the critical mass to drive change for people development, to help Europe retain its position in R&D in biomedical sciences. We warmly welcome further input and have set up a discussion forum on the on‑course® website”.

16. Did anybody listen?

17. LifeTrain The signatories to this European Common Framework for CPD in the biomedical sciences have agreed to the principles of the framework and to continue the collaboration in the implementation process.

18. LifeTrain’s key messages • Every professional in the biomedical sciences needs to develop and maintain an optimal level of professional competence in order to contribute to speeding up the development of better medicines for patients. • An individual competency portfolio should capture all relevant information in a transparent, easy-to-understand way in order to facilitate mobility between: scientific disciplines; academia, health authorities and industry; jobs and countries; and to support career development. • Continuing professional development (CPD) is essential and should be driven by each individual in agreement with their employer and in compliance with the requirements of the respective professional/scientific bodies. • CPD should be part of a “plan, do, review” cycle and can include formal, non-formal and informal learning. Each individual should reflect on the learning and its application in practice. • Objective assessments of competence should be made by the individual and by others, on a regular basis throughout the individual’s professional working life. • Needs should be identified and professional training courses developed and delivered in collaboration between industry, technical experts, and course providers (including universities). They should meet the needs of adult-learners and should be available on on-course®.

19. Professional/scientific bodies will: • Encourage members to establish and develop professional competencies by the provision of a framework for lifelong learning and professional recognition • Support their membership in the development and maintenance of a competency portfolio • Recognise the importance of relevant trans-disciplinary and generic competences • Recognise core competences from other IMI LifeTrain partner professional/scientific bodies • Work towards the implementation of the IMI Education and Training quality standard • Recognise continuing education courses that fulfil the appropriate IMI Education and Training standard as part of an individual’s CPD • Recognise the added value of periodic auditing of CPD records

20. The questions for LifeTrain

21. Thank you! www.emtrain.eu www.on-course.eu